TY - JOUR
T1 - Allergen-specific pattern recognition receptor pathways
AU - Wills-Karp, Marsha
N1 - Funding Information:
The author acknowledges support from NIH grants HL076383, HL67736-09, AI083315, ES015903, and AI070235 to M. Wills-Karp.
PY - 2010/12
Y1 - 2010/12
N2 - Allergic diseases continue to plague modernized societies, underscoring the need to identify the molecular basis for the propensity of a small number of environmental proteins to provoke maladaptive, allergic responses. Recent data suggest that the ability of allergenic proteins to drive allergic responses in susceptible hosts is driven by their unique innate immune activating capabilities. Although the identification of allergen-specific pattern recognition receptors is in its infancy, studies to date have shown that allergens drive Th2-biased immune responses via directly engaging C-type lectin receptors (dectin-2, DC-SIGN, and mannose receptor) on dendritic cells and/or mimicking toll-like receptor 4 signaling complex molecules expressed on airway structural cells. Elucidation of the specific innate immune pathways activated by allergens holds great promise in defining new therapeutic targets for the treatment of allergic diseases.
AB - Allergic diseases continue to plague modernized societies, underscoring the need to identify the molecular basis for the propensity of a small number of environmental proteins to provoke maladaptive, allergic responses. Recent data suggest that the ability of allergenic proteins to drive allergic responses in susceptible hosts is driven by their unique innate immune activating capabilities. Although the identification of allergen-specific pattern recognition receptors is in its infancy, studies to date have shown that allergens drive Th2-biased immune responses via directly engaging C-type lectin receptors (dectin-2, DC-SIGN, and mannose receptor) on dendritic cells and/or mimicking toll-like receptor 4 signaling complex molecules expressed on airway structural cells. Elucidation of the specific innate immune pathways activated by allergens holds great promise in defining new therapeutic targets for the treatment of allergic diseases.
UR - http://www.scopus.com/inward/record.url?scp=78649855748&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78649855748&partnerID=8YFLogxK
U2 - 10.1016/j.coi.2010.10.011
DO - 10.1016/j.coi.2010.10.011
M3 - Review article
C2 - 21093238
AN - SCOPUS:78649855748
SN - 0952-7915
VL - 22
SP - 777
EP - 782
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
IS - 6
ER -